Probiotics in reducing anxiety and depression symptoms: an integrative review

Detalhes bibliográficos
Autor(a) principal: Costa, Bruna Cunha
Data de Publicação: 2020
Outros Autores: Azevedo, George Silva dos Santos, Ferreira, Pedro Henrique Arruda, Rodrigues Almeida, Leila Magda
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Ciências em Saúde
DOI: 10.21876/rcshci.v10i4.1014
Texto Completo: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014
Resumo: Objectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.
id RCS_e4bcbe79b8e8c78235fda356f5080f64
oai_identifier_str oai:ojs.portalrcs.hcitajuba.org.br:article/1014
network_acronym_str RCS
network_name_str Revista Ciências em Saúde
spelling Probiotics in reducing anxiety and depression symptoms: an integrative reviewProbióticos na redução de sintomas de ansiedade e depressão: uma revisão integrativaanxietydepressionintestinal microbiotaprobioticsansiedadedepressãomicrobiota intestinalprobióticosObjectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.Objetivos: sumarizar estudos que avaliaram a suplementação de probióticos como estratégia terapêutica nos sintomas da ansiedade e depressão. Métodos: revisão integrativa de artigos indexados na base de dados PubMed, SciELO e Biblioteca Virtual em Saúde publicados de janeiro de 2010 a setembro de 2019. Para isso, utilizou-se a conjugação dos descritores: “intestino”, “cérebro”, “microbiota intestinal”, “ansiedade”, “depressão”, “probióticos”, nos idiomas português e inglês. Resultados: Após a aplicação dos critérios de inclusão e exclusão, 13 ensaios clínicos randomizados foram selecionados. O tempo de duração dos estudos, em sua maioria, foi de 8 ou 12 semanas (61,5%; n = 8), e a forma mais ofertada do suplemento foi o probiótico em pó (46,2%; n = 6) e em cápsula (30,8%; n = 4). Sobre a utilização de escalas como parâmetro de avaliação dos sintomas de ansiedade e depressão, 38,5% (n = 5) utilizaram apenas uma escala e 69,2% (n = 8) utilizaram a combinação de duas ou três escalas. Em relação ao gênero das bactérias, a maior parte dos estudos utilizou Lactobacillus e Bifidobacterium em conjunto (53,8%; n = 7). Apesar das limitações metodológicas e dos resultados inconsistentes, a maioria dos ensaios clínicos (76,9%; n = 10) evidenciaram uma redução significativa dos sintomas relacionados à ansiedade e depressão através da suplementação de probióticos. Conclusão: As evidências indicam que a suplementação com probióticos apresenta potencial promissor na redução dos sintomas de ansiedade e depressão, no entanto são necessárias pesquisas adicionais sobre essa estratégia como terapia adjuvante no tratamento efetivo para a saúde mental.AISI/HCI2020-12-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos parestextoinfo:eu-repo/semantics/otherapplication/pdftext/htmltext/xmlhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/101410.21876/rcshci.v10i4.1014Revista Ciências em Saúde; v. 10 n. 4 (2020): Outubro a Dezembro de 2020; 97-108Health Sciences Journal; Vol 10 No 4 (2020): October to December 2020; 97-1082236-378510.21876/rcshci.v10i4reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIporhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/619https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/654https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/655Copyright (c) 2020 Revista Ciências em Saúdehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessCosta, Bruna CunhaAzevedo, George Silva dos SantosFerreira, Pedro Henrique ArrudaRodrigues Almeida, Leila Magda2021-01-16T05:06:29Zoai:ojs.portalrcs.hcitajuba.org.br:article/1014Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2021-01-16T05:06:29Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse
dc.title.none.fl_str_mv Probiotics in reducing anxiety and depression symptoms: an integrative review
Probióticos na redução de sintomas de ansiedade e depressão: uma revisão integrativa
title Probiotics in reducing anxiety and depression symptoms: an integrative review
spellingShingle Probiotics in reducing anxiety and depression symptoms: an integrative review
Probiotics in reducing anxiety and depression symptoms: an integrative review
Costa, Bruna Cunha
anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
Costa, Bruna Cunha
anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
title_short Probiotics in reducing anxiety and depression symptoms: an integrative review
title_full Probiotics in reducing anxiety and depression symptoms: an integrative review
title_fullStr Probiotics in reducing anxiety and depression symptoms: an integrative review
Probiotics in reducing anxiety and depression symptoms: an integrative review
title_full_unstemmed Probiotics in reducing anxiety and depression symptoms: an integrative review
Probiotics in reducing anxiety and depression symptoms: an integrative review
title_sort Probiotics in reducing anxiety and depression symptoms: an integrative review
author Costa, Bruna Cunha
author_facet Costa, Bruna Cunha
Costa, Bruna Cunha
Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
author_role author
author2 Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
author2_role author
author
author
dc.contributor.author.fl_str_mv Costa, Bruna Cunha
Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
dc.subject.por.fl_str_mv anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
topic anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
description Objectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer reviewed
Avaliado pelos pares
texto
info:eu-repo/semantics/other
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014
10.21876/rcshci.v10i4.1014
url https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014
identifier_str_mv 10.21876/rcshci.v10i4.1014
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/619
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/654
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/655
dc.rights.driver.fl_str_mv Copyright (c) 2020 Revista Ciências em Saúde
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Revista Ciências em Saúde
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv AISI/HCI
publisher.none.fl_str_mv AISI/HCI
dc.source.none.fl_str_mv Revista Ciências em Saúde; v. 10 n. 4 (2020): Outubro a Dezembro de 2020; 97-108
Health Sciences Journal; Vol 10 No 4 (2020): October to December 2020; 97-108
2236-3785
10.21876/rcshci.v10i4
reponame:Revista Ciências em Saúde
instname:Hospital de Clínicas de Itajubá
instacron:HCI
instname_str Hospital de Clínicas de Itajubá
instacron_str HCI
institution HCI
reponame_str Revista Ciências em Saúde
collection Revista Ciências em Saúde
repository.name.fl_str_mv Revista Ciências em Saúde - Hospital de Clínicas de Itajubá
repository.mail.fl_str_mv rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br
_version_ 1822179480788008960
dc.identifier.doi.none.fl_str_mv 10.21876/rcshci.v10i4.1014